Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Revelation Biosciences (REVB)

Annual Return

Over the past 3 years, REVB has had an average annual return of -88.02%, underperforming the benchmark SPY, which returned +22.77% annual.

Over the past 5 years, REVB has had an average annual return of -92.33%, underperforming the benchmark SPY, which returned +14.05% annual.

Since Nov 17, 2020, REVB has had an average annual return of -89.13%, underperforming the benchmark SPY, which returned +15.97% annual.

202520242023202220212020
+0%-93.33%-92.31%-98.13%+1.50%+2.97%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2025+0%+0%
2024-40.00%-55.56%-25.00%-33.33%+0%+0%+0%-50.00%+0%+0%+0%+0%-93.33%
2023+57.44%-78.83%-41.54%-15.79%-3.12%-9.68%-14.29%-16.67%-0%-10.00%+16.67%-28.57%-92.31%
2022-75.39%-48.60%-11.65%-16.70%-44.71%+111.34%-49.25%-29.29%-34.56%+10.49%-30.51%-4.88%-98.13%
2021+0.70%+1.28%-2.53%+0.60%-0.50%+0.40%-0.29%+0.49%+0.20%+0.40%+0.19%+0.60%+1.50%
2020+2.36%+0.60%+2.97%

Drawdown analysis of Revelation Biosciences (REVB)

The maximum drawdown for the REVB was -99.99%, occurring on Jul 29, 2024. This drawdown has not yet recovered.

The current REVB drawdown is -99.99%.

Since Nov 17, 2020 REVB has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Jan 4, 2022643Jul 29, 2024OngoingOngoingOngoing
-6.86%Feb 4, 202118Mar 3, 2021213Jan 4, 2022231
-2.53%Dec 23, 20204Dec 30, 20208Jan 12, 202112
-1.74%Jan 12, 202112Jan 29, 20214Feb 4, 202116
-1.55%Dec 14, 20202Dec 16, 20205Dec 23, 20207
-0.91%Nov 30, 20201Dec 1, 20207Dec 10, 20208